Emkhakheni wesayensi yezimonyo ohlala ushintsha, i-Dimethylmethoxy Chromanyl Palmitate (DCP) ivela njengentuthuko entsha, ihlanganisa i-organic chemistry yanamuhla kanye nobuchwepheshe besikhumba. Njenge-ejenti yokwenza mhlophe yesizukulwane esilandelayo, le nhlanganisela ye-ester isebenzisa isakhiwo sayo esiyingqayizivele se-chromanoyl-palmitate ukuze ihlose i-melanogenesis emthonjeni, inikeze enye indlela ephephile nesebenza kahle kune-complexes evamile yokwenza mhlophe.
Iklanywe ngokwesayensi, i-DCP isebenza ngendlela ehlose kabili: ukuvimbela umsebenzi we-tyrosinase—isikhuthazi se-enzyme sokukhiqizwa kwe-melanin—nokukhuthaza ukujika kwe-keratinocyte ukuze kusheshiswe ukususwa kombala. Izivivinyo zemitholampilo zembula ukwehla okungu-41% kobuningi be-melanin zingakapheli izinsuku ezingu-28, okuhambisana nokuthuthuka okukhulu ekukhanyeni kwesikhumba kanye nokufana kwethoni. Ngokungafani nama-bleach amakhemikhali aqinile, ifomula yayo engacasuli ikhombisa ukuhambisana kwamaseli angu-98% (in vitro), okwenza ifaneleke esikhumbeni esibucayi kanye nokunakekelwa kwangemva kwenqubo.
“I-DCP imelela intuthuko eqhubekayo kwezokwelapha isikhumba ngokunemba,” kusho uDkt. Markus Hoffmann, umcwaningi oyinhloko e-Institute of Cosmetic Biochemistry. “Ngokulingisa uhlelo lwemvelo lokuvikela isikhumba olune-antioxidant, ifinyelela ukukhanya okuqondiwe ngenkathi iqinisa isithiyo sesikhumba—intuthuko ebalulekile ngaphezu kwezinto ezibangela ukuba isikhumba sibe mhlophe.”
Ukuhlaziywa kwemakethe kubikezela i-CAGR engu-34% yemikhiqizo efakwe i-DCP kuze kube ngu-2030, eqhutshwa yisidingo sabathengi sezinhlobo "zesayensi ehlanzekile". Izinkampani zobuhle zomhlaba wonke kanye nemikhiqizo ekhethekile zihlanganisa lesi sithako kuma-serum asezingeni eliphezulu, okhilimu bezinga lezokwelapha, kanye nezinhlelo zochwepheshe zokususa amagciwane, zisebenzisa izinhlelo zaso ezihlukahlukene—kusukela ekulungisweni kwe-melasma kuya ekuvimbeleni ukudabuka.
Ukuthobela imithetho kuyisisekelo sentuthuko ye-DCP. Le nhlanganisela inamathela ezindinganisweni zokuphepha ze-EU (EC 1223/2009) kanye ne-US (FDA 21 CFR § 73.615), ngokuhlolwa kobuthi okuqinisekisa ukuthi akukho mandla okuguqula i-mutagenic, i-carcinogenic, noma i-teratogenic. Inqubo yayo yokwenziwa enobungani nemvelo inciphisa ukunyathela kwekhabhoni ngo-58% uma kuqhathaniswa nama-agent ajwayelekile okwenza kube mhlophe, okuhambisana nezidingo zokuzinza kwemboni.
Njengoba imboni yobuhle ishintshela ezixazululweni ezisekelwe ebufakazini, ezigxile esikhumbeni, i-DCP iwubufakazi bokusungula izinto ezintsha ngobuqotho—iletha imiphumela elinganisekayo ngokuklama ama-molecule ngenkathi ibeka phambili ukuphepha, ukusebenza kahle, kanye nomthwalo wemfanelo wemvelo. Lokhu akuyona nje into yokwenza mhlophe; kuyinguquko ebonakalayo ekupheleleni kwesikhumba.
Isikhathi sokuthunyelwe: Ephreli-30-2025
